Cite
HARVARD Citation
Ray-Coquard, I. et al. (n.d.). 934OAlienor/ENGOT-ov7 randomized trial exploring weekly paclitaxel (wP) + bevacizumab (bev) vs wP alone for patients with ovarian sex cord tumors (SCT) in relapse. Annals of oncology. p. . [Online].